OpenLegislation

Division 21.3

United Kingdom

Original text. Later amendments are not shown.

The use of animals for antibody production for commercial purposes, including immunisation for the subsequent hybridoma production, shall be reported under ‘Monoclonal and polyclonal antibodies (excluding ascites method)’.